- Morning Sickness
- Drugs in Pregnancy
- Alcohol, Nicotine, Substance Use
- Folic Acid
- Breastfeeding & Drugs
- Cancer in Pregnancy
- HIV and HIV Treatment
- Conditions in Pregnancy
- Infectious Diseases in Pregnancy
- Nutrition
- Occupational & Environmental Exposures
- Pharmacokinetics/ Drug Metabolism
- PregTox
- The ReproPsych Group
- CAS Newsletter
Our Helplines
1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
St. John's,NL
2013 FACE meeting
Orlando, Florida
Fetal Alcohol Canadian Expertise (FACE) Satellite Meeting
.
-
Jul192012
-
Mar292012
-
Jul282011
-
Jan272011
- Read more in our News Archive
Current Studies at Motherisk
-
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
-
Pregnancy in Women with Multiple Sclerosis
-
Environmental Exposures and Children's Health
-
Alcohol Use during Pregnancy
-
Control of Hypertension in Pregnancy Study
-
Folic Acid Before and During Pregnancy
-
Lamisil in Pregnancy
-
Meridia in Pregnancy
-
Autoimmune Diseases in Pregnancy Project
Exposures in Pregnancy: Teratogen Information Services - Models & Approaches
Motherisk Research
-
Reprod Toxicol 2002 Jan-Feb:16(1):77-80
Bailey B, Forget S, Koren G: Pregnancy outcome of women who failed appointments at a teratogen information service clinic. -
Reproductive Toxicology 10(2):165, 1996 Mar-Apr. No abstract available.
Einarson A, Langos R, Gallo M, Moretti M, McMartin K: Motherisk: a teratology counselling service [letter]. -
Koren G: New expectations for the role of clinical pharmacologists and industry in protecting unborn babies and their mothers. Canadian Journal of Clinical Pharmacology 4/2 (62-63) 1997
-
Bratislava Medical Letters 92: 615-618, 1991.
Koren G: Monitoring adverse drug reactions in pregnancy and lactation; The Motherisk Model -
J Clin Pharmacol 33: 405-411, 1993.
Koren G, Graham K, Feigenbaum A, Einarson T: Evaluation and counseling of teratogenic risk; The Motherisk Approach. -
Vet Hum Toxicol 28: 563-565, 1986. No abstract available.
Koren G, Feldman Y, Shear N: Motherisk - A new approach to drug/chemical teratogenicity. -
J Pharm Pract 6: 1-7, 1993.
Koren G, Graham K, Feigenbaum A, Einarson T: Evaluation and counseling of teratogenic risk: The Motherisk Approach. -
Pellegrini E, Koren G: The Motherisk Program-Pregnancy and drug counseling. On Continuing Practice 15:2-6, 1988.
-
Koren G: The Motherisk Program. IM Print. 4:4-5, Fall 1992.
-
Reprod Toxicol 6: 293-295, 1992. No abstract available.
Koren G: A quality assurance program for Teratogen Information Services. -
Repod Toxicol 8: 419-424, 1994.
Magee LA, Koren G: The use of teratogen information services for research; Assessment of reliability of data entry. -
Koren G, Feldman Y, MacLeod S: Motherisk II: Summary of first year. In: Maternal-Fetal Toxicology (G Koren, ed), Marcel Dekker, NY 383-402, 1990.
In Book: -
Journal of Adolescent Health 1997 Sep;21(3):143
Shilalukey K, Kaufman M, Bradley S, Francombe WH, Amankwah K, Goldberg E,Shear N, Olivieri NF, Koren G: Counseling sexually active teenagers treated with potential human teratogens. -
Teratology. 1999 Sep;60(3):130-6.
McMartin KI, Koren G: Proactive approach for the evaluation of fetal safety in chemical industries.












![Validate my RSS feed [Valid RSS]](/images/rssValid.png)